These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 17682981)

  • 21. Schistosomiasis does not contribute to death or recurrence of nontyphoid Salmonella bacteremia in human immunodeficiency virus-infected Malawian adults.
    Gordon MA; Zijlstra EE; Naus CW; Visser LG; Molyneux ME; van Lieshout L
    Clin Infect Dis; 2003 Dec; 37(12):e177-9. PubMed ID: 14689364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects.
    Tompkins JC; Witzig RS
    Int J Tuberc Lung Dis; 2007 Mar; 11(3):331-7. PubMed ID: 17352101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
    Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
    Bolhaar MG; Karstaedt AS
    Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.
    Jordano Q; Falcó V; Almirante B; Planes AM; del Valle O; Ribera E; Len O; Pigrau C; Pahissa A
    Clin Infect Dis; 2004 Jun; 38(11):1623-8. PubMed ID: 15156452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
    Heard I; Potard V; Costagliola D
    Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of antiretroviral multiclass resistance.
    Lima VD; Harrigan PR; Sénécal M; Yip B; Druyts E; Hogg RS; Montaner JS
    Am J Epidemiol; 2010 Aug; 172(4):460-8. PubMed ID: 20667931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
    Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
    Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
    HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isosporiasis in patients with HIV infection in the highly active antiretroviral therapy era in France.
    Lagrange-Xélot M; Porcher R; Sarfati C; de Castro N; Carel O; Magnier JD; Delcey V; Molina JM
    HIV Med; 2008 Feb; 9(2):126-30. PubMed ID: 18257775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
    Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
    Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era.
    Kramer JR; Giordano TP; Souchek J; El-Serag HB
    J Hepatol; 2005 Mar; 42(3):309-14. PubMed ID: 15710213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era.
    Abgrall S; Rabaud C; Costagliola D;
    Clin Infect Dis; 2001 Nov; 33(10):1747-55. PubMed ID: 11595976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The oncology impact of highly active antiretroviral therapy.
    Schlichemeyer R; Chambers C; Gill MJ
    J Oncol Pharm Pract; 2007 Mar; 13(1):17-25. PubMed ID: 17621563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients.
    Kosmas N; Kontos A; Panayiotakopoulos G; Dimitrakopoulos A; Kordossis T
    J Med Virol; 2006 Oct; 78(10):1257-61. PubMed ID: 16927287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extraintestinal focal infections in adults with nontyphoid Salmonella bacteraemia: predisposing factors and clinical outcome.
    Chen PL; Chang CM; Wu CJ; Ko NY; Lee NY; Lee HC; Shih HI; Lee CC; Wang RR; Ko WC
    J Intern Med; 2007 Jan; 261(1):91-100. PubMed ID: 17222172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
    Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.
    Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS
    Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
    J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.